$1.90
0.02[1.06%]
At close: Apr 24
$1.90
0[0.00%]
After Hours: 8:10AM EDT
TherapeuticsMD
(NASDAQ:TXMD)TherapeuticsMD Stock (NASDAQ:TXMD), Analyst Ratings, Price Targets, Predictions
TherapeuticsMD Inc has a consensus price target of $7.5, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Cantor Fitzgerald, and Cantor Fitzgerald on August 17, 2023, January 11, 2023, and July 13, 2022. With an average price target of $3.67 between Cantor Fitzgerald, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 92.98% upside for TherapeuticsMD Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for TherapeuticsMD
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/17/2023 | TXMD | Buy Now | TherapeuticsMD | $1.90 | 163.16% | Cantor Fitzgerald | Louise Chen | → $5 | Reiterates | Neutral → Neutral | Get Alert |
| 01/11/2023 | TXMD | Buy Now | TherapeuticsMD | $1.90 | 163.16% | Cantor Fitzgerald | Louise Chen | → $5 | Reinstates | → Neutral | Get Alert |
| 07/13/2022 | TXMD | Buy Now | TherapeuticsMD | $1.90 | -47.37% | Cantor Fitzgerald | Louise Chen | → $1 | Reiterates | → Neutral | Get Alert |
| 06/07/2022 | TXMD | Buy Now | TherapeuticsMD | $1.90 | 426.32% | HC Wainwright & Co. | Douglas Tsao | → $10 | Downgrade | Buy → Neutral | Get Alert |
| 05/06/2022 | TXMD | Buy Now | TherapeuticsMD | $1.90 | -47.37% | Cantor Fitzgerald | Louise Chen | $250 → $50 | Downgrade | Overweight → Neutral | Get Alert |
| 03/11/2022 | TXMD | Buy Now | TherapeuticsMD | $1.90 | 31.58% | HC Wainwright & Co. | Douglas Tsao | $150 → $125 | Maintains | Buy | Get Alert |
| 11/12/2021 | TXMD | Buy Now | TherapeuticsMD | $1.90 | 57.89% | HC Wainwright & Co. | Douglas Tsao | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for TherapeuticsMD (TXMD)?
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on August 17, 2023. The analyst firm set a price target for $5.00 expecting TXMD to rise to within 12 months (a possible 163.16% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TherapeuticsMD (TXMD)?
The latest analyst rating for TherapeuticsMD (NASDAQ: TXMD) was provided by Cantor Fitzgerald, and TherapeuticsMD reiterated their neutral rating.
When was the last upgrade for TherapeuticsMD (TXMD)?
There is no last upgrade for TherapeuticsMD.
When was the last downgrade for TherapeuticsMD (TXMD)?
The last downgrade for TherapeuticsMD Inc happened on June 7, 2022 when HC Wainwright & Co. changed their price target from N/A to $10 for TherapeuticsMD Inc.
When is the next analyst rating going to be posted or updated for TherapeuticsMD (TXMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TherapeuticsMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TherapeuticsMD was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.
Is the Analyst Rating TherapeuticsMD (TXMD) correct?
While ratings are subjective and will change, the latest TherapeuticsMD (TXMD) rating was a reiterated with a price target of $0.00 to $5.00. The current price TherapeuticsMD (TXMD) is trading at is $1.90, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.